What is Gemscript?
Gemscript is a new integrated DM+D drug dictionary for Vision that adheres to NHS standards. It allows the clear and unambiguous identification of specific medicines and devices, and will soon replace the existing Multilex drug dictionary within Vision.
How will the move to Gemscript improve Vision?
Sharing patient information between healthcare workers is becoming increasingly important, but to do this well everyone needs to be using the same drug coding system. Gemscript uses the NHS DM+D system so it provides an accurate and reliable foundation for the electronic exchange of information about medicines and devices between healthcare workers and organisations. As patient record sharing and interoperability between clinical systems becomes more common, this has significant safety benefits for patients and the quality of their healthcare provision.
There are benefits for Vision users too. Gemscript improves Vision’s decision support toolset, including better allergy and sensitivity checks, country specific drug details (such as black lists) and alerts are more relevant to the selected patient.
There is a further change that will be very popular with Vision users – they will no longer need to run the Therapy Update utility, as that function will be included in the monthly updates!
When will practices get Gemscript?
Gemscript is being delivered to all practices that use Vision in DLMs 400 and 401 early this summer.
How will Gemscript affect end-users?
The change to Gemscript should not affect Vision users very much. However, there are a few things they will need to change, or to train their staff on. They will need to run a utility to update drug names to DM+D. The time needed to do this will vary between practices depending on prescribing patterns and the specification of the equipment at your practice.
When searching, drugs will sometimes appear in a different order in the selection list because Gemscript uses DM+D descriptions. This also means the format will become name-strength-form (i.e. Aspirin 75mg tablets) instead of name-form–strength (i.e. Aspirin tab 75mg).
After Gemscript is installed Drug Action Group categories will be referred to as Drug Classes throughout Vision. In some cases there is no exact match between Gemscript Drug Classes and existing Drug Action Group categories so users are advised to review any practice guidelines that contain drug filters or drug regimes and any ad-hoc searches that contain Drug Action Group (particularly appliance drug action groups) search criteria. Otherwise the guideline or search may produce unexpected results.
All practices with a drug formulary are advised to check their formulary list for items that have no DM+D equivalent. These items are no longer available to prescribe but still appear in your formulary list in Drug Dictionary Utilities. Practices should locate these items and add an alternative DM+D item where necessary. These items can then be removed from the formulary list from the Search and Reports module.
Who maintains Gemscript?
Gemscript is produced and maintained by a company called RESIP UK, which is part of the same family of companies as INPS. We have worked closely with RESIP UK on the integration of Gemscript into Vision, and we believe this close relationship will be beneficial to Vision users because we will be able to respond more quickly to changes in the availability of pharmaceutical products.
Where is there more information about Gemscript?
There is a Gemscript page on the INPS website here. On this page there is a link to a Frequently Asked Questions information sheet that can be downloaded. The DLM 400 user guide is also available in the User Assistance area of the INPS website.